Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Recent patents disclose novel agents for the treatment of neurological disorders

Oct. 27, 2005

LY-156735 improves sleep parameters in moderate to severe insomnia

Oct. 27, 2005

Reversal of neuromuscular block achieved with ORG-25969

Oct. 27, 2005

RJR-2403 assessed in Alzheimer's disease model

Oct. 27, 2005

Adjunctive levetiracetam reduces primary tonic-clonic seizures in patients with IGE

Oct. 27, 2005

New data on the analgesic effects of gabapentin

Oct. 27, 2005

MHRA accepts for review Dyoject MAA

Oct. 27, 2005

In vivo efficacy of SL-65.0155 in Alzheimer's model

Oct. 27, 2005

Antidepressant efficacy of the selective mGluR5 antagonist, MTEP, shown in rodents

Oct. 27, 2005

Cognitive parameters improved with ispronicline in age-associated memory impairment

Oct. 26, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026